Company / Shareholders' Equity
KALA BIO, Inc. Shareholders' Equity History
FY2017-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
-$87.8M
FY2017
5-year range
-$87.8M / -$87.8M
FY2017-FY2017
Trend
-
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-$88M in FY2017.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.02 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2017 | -$87.8M | - |
As of FY2017 · SEC 10-K · Updated Jun 24, 2026